L'Air Liquide S.A.

AI.PA Q2 2026

Reported: 2026-07-30

Air Liquide shares declined 3.2% following the earnings release as cautious outlook indicators and margin pressures raised investor concerns despite solid project signings and revenue growth.

Key takeaways

Comparable sales growth accelerated from 1.9% in Q1 to 3.5% in Q2, supported by Electronics and Industrial Merchant segments.
Margin progression reached +110 basis points, but increased investments likely tempered profitability expectations.
Recurring net profit grew 10% with cash flow up 8%, excluding currency effects.
Record new project signings of over EUR 1 billion in Electronics and major investments totaling over $1 billion in Large Industries underpin future growth.
Market reaction suggests investors remain cautious on sustainability of margins and overall outlook despite solid operational execution.

View recap

American Tower Corporation (REIT)

AMT Q2 2026

Reported: 2026-07-30

American Tower’s shares rose 7.5% following better-than-expected leasing demand and record activity at CoreSite, prompting an upward revision to full-year growth outlooks.

Key takeaways

Raised full-year revenue growth outlook to approximately 15% for the data center business and ~4% organic tenant billings growth for the global tower portfolio.
Record leasing activity at CoreSite driven by broad-based demand including hyperscale cloud providers and AI innovators.
Industry trends such as 5G capacity expansion, new spectrum deployment, and emerging 6G and AI applications bolster long-term infrastructure demand.
CoreSite positioned as a critical digital infrastructure hub, hosting 9 of the top 10 AI companies and supporting growing AI and cloud-to-cloud workloads.
Management cites operational discipline and disciplined capital allocation as factors contributing to sustained momentum.

View recap

Applied Science Products, Inc.

APLD Q4 2026

Reported: 2026-07-30

Shares declined 2.1% despite Applied Digital's substantial long-term lease signings and expansion, reflecting investor caution as bullish contract value growth failed to offset concerns about execution risks and cautious forward visibility. While contract signings and project scale are impressive, the modest post-earnings stock drop signals skepticism about near-term execution risks and the ability to sustain growth momentum amid evolving market conditions.

Key takeaways

Signed leases representing $36 billion in total contracted long-term lease value, with $20 billion added in the quarter alone.
Contracted critical IT load now totals 1.41 gigawatts with multiple campuses under construction for several hyperscalers.
Actively marketing an additional 1.7 gigawatts expected to command higher pricing amid favorable rental rate trends.
Pipeline includes expansion options for 250 megawatts at existing sites, potentially adding over $6 billion in contracted revenue.
Progressing on power infrastructure development via Base Electron, holding a 10% stake in an independent power producer targeting 1.2 gigawatts capacity.

View recap

The Boeing Company

BA Q2 2026

Reported: 2026-07-30

Boeing's shares rose modestly by 1.2% after its Q2 report as the company made steady progress on certification milestones and production ramp-ups, though cost pressures on fixed-price defense programs and a cautious supply chain update limited upside for investors.

Key takeaways

Commercial Airplanes production ramps continued with 737 MAX reaching 47 units per month and plans for 52 units monthly under way; 787 production stabilized at 8 units per month after temporary slowdown to aid supply chain recovery.
Certification progress remains on track with FAA approvals for 737-7 and -10 variants pending and 55% of 777-9 flight testing completed, supporting deliveries expected in 2027.
Defense and Space secured low-rate initial production approvals for T-7 and MQ-25 and advanced KC-46A upgrades, although the VC-25B program incurred a $280 million charge due to increased costs and schedule risk mitigation.
Supply chain transparency efforts continue but remain critical as temporary production slowdowns highlight ongoing vulnerabilities.
Boeing reiterated a constructive demand outlook with a backlog above 6,200 airplanes and a commercial market forecast near 44,000 new planes over 20 years.

View recap

Basic-Fit N.V.

BFIT.AS Q2 2026

Reported: 2026-07-30

The stock surged 12.5% post-earnings, driven by better-than-expected organic membership growth and accelerating club expansion, underscoring strong underlying momentum and a clear path to improved returns through the multivertical growth strategy.

Key takeaways

Membership base expanded 34% year-over-year to 6.1 million, including 13% organic growth for Basic-Fit branded clubs (5.1 million members).
Total clubs increased modestly by 41 net new locations to 2,190, with 35 organic owned club openings supporting continued network expansion.
Underlying EBITDA less rent rose 36% to €204 million, ahead of internal targets and indicative of improving operational leverage.
The upcoming acquisition of Wellyou will add 41 clubs and 110,000 members in Germany, accelerating critical mass in a key growth market.
The company maintains disciplined capital allocation focused on generating low- to mid-teen group ROCE through organic growth, inorganic acquisitions, and new franchising initiatives.

View recap

Banco Latinoamericano de Comercio Exterior, S.A

BLX Q2 2026

Reported: 2026-07-30

Bladex’s shares declined 3.7% post-earnings, reflecting investor concerns over margin compression despite solid portfolio growth and record noninterest income; pressure on net interest margin and cautious margin outlook outweighed the revenue diversification gains.

Key takeaways

Net interest margin declined 10 basis points to 2.24%, pressured by higher liquidity and competitive spreads, signaling ongoing margin compression.
Commercial portfolio grew 8% sequentially to $13 billion, up 20% year-over-year, driven by loans and contingencies across diversified markets.
Noninterest income surged 86% quarter-over-quarter to a record $25 million, representing 26% of total revenues and illustrating progress in revenue diversification.
Expenses increased, consistent with strategic investments, but efficiency improved to 24.1% as revenue growth outpaced costs.
Provisions rose due to strong portfolio growth and conservative risk management, while asset quality and capital ratios remained sound with a Tier 1 capital ratio of 16.6%.

View recap

Brixmor Property Group Inc.

BRX Q2 2026

Reported: 2026-07-30

Shares of Brixmor Property Group declined 2.1% following the earnings release, reflecting investor caution despite solid operational execution and pipeline growth. The market appears to weigh the modest sequential occupancy dip and ongoing redevelopment-related impacts against positive leasing spreads and reinvestment activity.

Key takeaways

Same-property NOI grew 5.8%, supported by strong tenant demand and broad-based leasing activity.
Executed 1.4 million square feet of new and renewal leases at a 19% blended cash spread; new lease spreads remained above 30% for three years.
Total leased occupancy ended at 94.8%, down 30 basis points sequentially, driven by expected move-outs related to redevelopment and recaptured boxes.
Signed but not yet commenced lease pipeline reached a record $71 million of annualized base rent, with significant commencements expected in 2027 and beyond.
Active reinvestments totaled nearly $350 million with an expected incremental yield of 10%, bolstered by four strategic acquisitions totaling $164 million.

View recap

Cincinnati Financial Corporation

CINF Q2 2026

Reported: 2026-07-30

Shares declined 1.6% following Q2 results as investors weighed higher combined ratios driven by increased catastrophe losses and slowing premium growth amid ongoing pricing discipline, signaling underlying margin pressure despite stable underwriting metrics.

Key takeaways

Net income was nearly $1.3 billion, boosted by a $882 million after-tax unrealized gain on equity securities; non-GAAP operating income fell to $224 million from $311 million a year ago.
The property casualty combined ratio worsened to 100.8%, up 5.9 points year-over-year, with catastrophe losses adding 2.3 points, reflecting margin compression in underwriting.
Premium growth slowed to 3% overall, with commercial lines and excess & surplus lines growing modestly, while personal lines saw only 1% growth amid weaker new business.
Expense ratio rose 1.2 points in the quarter due to commissions and expense timing, partially offsetting investment income growth.
Investment income increased 12%, supported by higher yields and portfolio rebalancing, though portfolio fixed maturities remain at a net unrealized loss.

View recap

Celestica Inc.

CLS Q2 2026

Reported: 2026-07-30

Celestica’s Q2 results beat expectations with revenue and adjusted EPS surpassing guidance, driving a 3.2% stock gain. Strong demand across CCS and ATS segments, along with margin expansion, underpin the positive market reaction.

Key takeaways

Revenue reached $4.7 billion, up 62% year-over-year, exceeding the high end of guidance.
Adjusted EPS was $2.54, an 83% increase and above the high end of the guidance range.
Adjusted operating margin improved 80 basis points to 8.2%, a company record driven by operating leverage.
CCS segment revenue rose 84%, led by 800G networking and accelerated AI/ML compute program ramps; CCS accounted for 81% of revenue.
ATS revenue grew 8% and margin expanded 100 basis points, benefiting from both volume growth and a higher engineering product mix.

View recap

CenterPoint Energy, Inc.

CNP Q2 2026

Reported: 2026-07-30

Shares declined 2.5% following the quarter as investors appeared cautious on the company's cautious outlook and incremental capital spending, despite stable earnings and growth commentary.

Key takeaways

Reported Q2 2020 GAAP EPS of $0.37 and non-GAAP EPS of $0.40, in line with prior guidance.
Reiterated full-year 2026 non-GAAP EPS guidance range of $1.89 to $1.91, implying mid-single digit growth, but no upward revision.
Announced a $1.2 billion increase in the 10-year capital investment plan, raising spending amid anticipated system upgrades and growth projects.
Highlighted significant demand growth with 17 GW of large load project submissions to ERCOT’s batch zero, 14 GW expected to qualify, representing over 65% increase in system peak demand.
Emphasized expected customer affordability benefits of $5 billion savings over 10 years but did not provide incremental margin or profitability outlook related to increased capex.

View recap

Croda International Plc

CRDA.L Q2 2026

Reported: 2026-07-30

Shares rose 10.1% following results that demonstrated accelerating growth in Consumer Care, particularly Beauty Actives, and margin expansion supported by transformation cost savings, confirming confidence in the unchanged full-year outlook.

Key takeaways

Constant currency sales increased 5% to GBP 881 million, led by 8% growth in Consumer Care and 7% growth in Pharma Ingredients.
Beauty Actives sales surged 27% in Q2, benefiting from customer innovation and product launches, driving improved second-quarter performance.
Adjusted operating profit rose 7% to GBP 156 million, with a 50 basis point margin expansion driven by higher volumes, pricing, mix, and GBP 18 million in transformation cost savings.
Free cash flow improved to GBP 38 million, with net debt and leverage remaining stable and conservative at 1.4x EBITDA.
Full-year guidance remains unchanged, with expected organic sales growth of 3% to 6% and margin expansion, supported by a strong pipeline and ongoing transformation.

View recap

CoStar Group, Inc.

CSGP Q2 2026

Reported: 2026-07-30

The stock edged up modestly by 2.3% following Q2 results that continued steady revenue growth and margin improvement, though the market's tepid reaction suggests tempered enthusiasm amid ongoing restructuring at Ten-X and no significant upside to guidance.

Key takeaways

Revenue rose 18% year-over-year to $925 million, marking 61 consecutive quarters of double-digit revenue growth.
Adjusted EBITDA more than doubled year-over-year to $184 million, reaching the company's second highest quarterly level; operating costs increased only 2%.
Commercial real estate segment revenue grew 8% to $481 million with adjusted EBITDA up 7%, while CoStar segment revenue increased 9% to $337 million alongside a 24% acceleration in net new bookings.
Ten-X revenue declined by $4 million amid restructuring efforts that cut costs by $7 million year-to-date, signaling challenges as the unit resets.
Continued expansion with launches in France and the UK, and further product innovation, including AI-powered lease abstraction and advancing presence in Australia.

View recap

CTS Corporation

CTS Q2 2026

Reported: 2026-07-30

CTS reported a modest 1.9% stock increase following Q2 earnings, reflecting solid revenue growth and margin expansion balanced against modest transportation declines and cautious near-term segment performances.

Key takeaways

Revenue grew 7% year over year to $145 million, led by a 15% increase in diversified end markets, which now represent 59% of total sales.
Adjusted gross margin reached a record 41.5%, up 270 basis points year over year; adjusted EBITDA margin improved by approximately 240 basis points to 25.4%.
Adjusted diluted EPS was a record $0.74, benefiting from roughly $0.07 per share of unusual items.
Medical end market sales rose 45% year over year to $28 million, supported by strong demand and a book-to-bill ratio of 1.21.
Transportation sales declined 2% year over year and sequentially, reflecting ongoing softness in that segment despite new business awards totaling $163 million.

View recap

Ecolab Inc.

ECL Q2 2026

Reported: 2026-07-30

Ecolab's shares rose 4.5% following better-than-expected pricing strength and accelerating organic sales growth, with key growth engines delivering robust volume gains and margin stability despite rising commodity costs.

Key takeaways

Adjusted EPS grew 11%, supported by a 5% organic sales increase and stable gross margins despite commodity cost inflation.
Pricing improved to 4% in Q2, with expectations for 5% to 6% pricing in H2, offsetting cost pressures effectively.
Volume growth was 1%, despite a ~1% headwind from Middle East disruptions; core businesses accelerated with food & beverage up 7%, institutional & specialty 4%, and life sciences 15%.
Life sciences achieved a mid-20% operating margin this quarter, though third-quarter margin guidance moderates to high teens due to ongoing investments.
Global high-tech continued rapid expansion, with 29% sales growth and a recent acquisition bolstering scale and raising growth and margin targets for this segment.

View recap

EssilorLuxottica Societe anonyme

EL.PA Q2 2026

Reported: 2026-07-30

EssilorLuxottica reported stable H1 2026 results with solid revenue and profit growth, but the stock was largely unchanged (-0.2%) as investors balanced the company’s ongoing transformation and innovation against limited near-term financial acceleration.

Key takeaways

Revenue grew 9.7% at constant currency, driven by frames, lenses, and significant growth in clinical and wearable segments.
Adjusted operating profit increased 15%, reflecting operating leverage despite ongoing investments in R&D, AI, and medical capabilities.
Cash generation remained strong, exceeding €1 billion in the first half.
Strategic initiatives include the launch of LensCrafters’ integrated eye health surgery center and a partnership with Applied Materials to develop next-generation AI and AR eyewear technologies.
Wearables category expanded with new Ray-Ban Meta Optical models and growing profitability, though broader market adoption remains an investment focus.

View recap

Man Group plc

EMG.L Q2 2026

Reported: 2026-07-30

Man Group’s shares gained 3.3% following a solid first half highlighted by broad-based investment performance, record assets under management (AUM), and strong net inflows, indicating that the market welcomed the diversified revenue growth and recovery trends in key strategies.

Key takeaways

Record AUM reached $253.6 billion, increasing 11% year-to-date from both $19.8 billion of investment performance and $7.1 billion of net inflows.
Net management fees rose 21% year-over-year to $627 million, supporting core net revenue of $853 million and a pre-tax profit margin of 35%.
Liquid alternatives AUM climbed to $92.9 billion, driven by positive investment performance (+$4.2 billion) despite a first-quarter net outflow, which reversed in Q2 with solid client demand.
Performance fees more than tripled from H1 2025 to $207 million, reflecting contributions across multiple strategies including liquid alternatives and private markets.
Not all strategies performed equally; for example, AHL Evolution returned -3.7%, consistent with challenges across similar trend-following programs.

View recap

Ford Motor Company

F Q2 2026

Reported: 2026-07-30

The stock rose 4.1% following earnings, driven by an upward revision in full-year adjusted EBIT guidance and strong performance in core truck sales and margin-accretive software and services initiatives.

Key takeaways

Raised and narrowed full-year adjusted EBIT guidance to $10 billion–$11 billion, a $1 billion increase at the midpoint.
Achieved $2.5 billion in adjusted EBIT on $48.3 billion in revenue for the quarter.
F Series truck remains the number one brand in the U.S., outselling the nearest competitor by over 80,000 units in H1.
Off-road models (Bronco, Tremor, Raptor) now account for 25% of U.S. sales, attracting younger and more affluent buyers.
Continued investment in EVs with progress on the Louisville plant conversion and first UEV platform vehicles expected to launch next year.

View recap

Corning Incorporated

GLW Q2 2026

Reported: 2026-07-30

Shares fell 13.5% following the earnings release, reflecting investor disappointment with the cautious outlook and potential deceleration implied in management’s longer-term guidance. Despite strong revenue and profit growth in the quarter, the market focused on tempered forward growth assumptions and less optimistic end-market conditions.

Key takeaways

Q2 sales grew 17% year-over-year to $4.74 billion, supported by a 32% increase in Optical Communications sales to over $2 billion.
EPS increased 30% to $0.78, and gross margin expanded 120 basis points to 39.6%, driven by operating margin improvement of 190 basis points to 20.9%.
Free cash flow rose to $1.42 billion, reflecting solid cash conversion.
Management reiterated a 19% sales CAGR target for 2027-2030 but incorporated assumptions of flat end markets in TV, IT, and smartphones, plus declining internal combustion engine demand partially offset by automotive content gains.
Despite upgrades in solar wafer capacity and significant multi-billion dollar customer agreements, guidance appears cautious, with risk-adjusted plans factoring in weaker growth potential, which likely weighed on investor sentiment.

View recap

Grifols, S.A.

GRF.MC Q2 2026

Reported: 2026-07-30

Grifols shares rose 5.2% following Q2 earnings, buoyed by biopharma revenue growth that surpassed expectations and a cautious but confident outlook on operational execution and pipeline progress.

Key takeaways

Q2 adjusted EBITDA margin improved to 25.2%, supporting profitability amid disciplined commercial execution.
Biopharma segment grew 5.4%, driving overall 2.6% constant currency revenue growth in H1 2026.
Free cash flow rose by approximately €100 million in the first half, reflecting operational discipline and working capital efficiency.
New product launches and ongoing Phase III trials (e.g., GAMUNEX-C, XEMBIFY) indicate pipeline advancement in immunoglobulin and protein therapies.
Strategic initiatives include expanding plasma collection in Egypt and Canada and preparations for potential IPO of the U.S. Biopharma unit.

View recap

GlaxoSmithKline plc

GSK.L Q2 2026

Reported: 2026-07-30

Gibson Energy’s shares rose modestly by 2.3% following a solid second quarter marked by record infrastructure EBITDA and improved marketing results, though the market’s tepid response suggests tempered enthusiasm amid ongoing commodity volatility and cautious growth execution.

Key takeaways

Infrastructure adjusted EBITDA hit a record CAD 169 million, up CAD 17 million year-over-year, driven by stronger utilization, the Chauvin acquisition, and optimization efforts expanding throughput by ~8 million barrels.
Marketing contributed CAD 18 million in adjusted EBITDA year-to-date, with second quarter performance benefiting from crude volatility and strengthened crack spreads.
The Chauvin Pipeline acquisition closed on May 1, expanding Gibson’s footprint and contracted cash flows, with connection and expansion projects underway targeting completion and investment decisions by early 2027.
U.S. growth projects advanced with the Wink to Gateway integration nearing completion, enhancing supply access from major basins.
Despite constructive macro trends and record results, ongoing volatility in freight rates, vessel availability, and commodity prices remain risks the company is monitoring closely.

View recap

Hilton Worldwide Holdings Inc.

HLT Q2 2026

Reported: 2026-07-30

Hilton’s shares declined 2.8% following the earnings report, reflecting investor caution despite stable operational performance and continued development momentum. While the company raised its full-year RevPAR guidance, concerns lingered around external pressures such as geopolitical risks and calendar-related demand shifts dampening overall enthusiasm.

Key takeaways

System-wide RevPAR grew 3.9% year-over-year in Q2, driven by strong U.S. business transient and group demand, aided by World Cup-related leisure travel.
Raised full-year RevPAR growth guidance to 3.0–3.5%, expecting Q3 above and Q4 below that range due to calendar shifts and midterm elections.
Development remained robust with over 200 hotel openings (up 50% from Q1) and the second-largest quarterly signings in company history at ~43,000 rooms.
Nearly half of Hilton’s 541,000-room pipeline is under construction, supporting expected 6–7% net unit growth.
Market concerns likely reflect geopolitical headwinds (Middle East conflict), holiday season timing, and modest margin pressure implied by cautious tone on demand outlook.

View recap

Hubbell Incorporated

HUBB Q2 2026

Reported: 2026-07-30

Hubbell's shares fell 7.4% following the quarter as investors reacted negatively to margin compression despite solid sales growth, signaling concerns about rising inflationary pressures and margin sustainability amid investments and integration costs.

Key takeaways

Net sales grew 15% year-over-year to $1.712 billion, driven by 10% organic growth and 5% from acquisitions including NSI.
Organic growth was led by 6% in Utility Solutions and 18% in Electrical Solutions, with acceleration noted in electric distribution and data center markets.
Adjusted operating profit increased 13% to $409 million, but adjusted operating margins contracted modestly to 23.9% versus a strong prior-year comparison.
Inflationary headwinds persist despite ongoing price and productivity measures; margin pressure reflects rising costs and investments in capacity expansion.
The acquisition of NSI is expected to be accretive starting in 2026, but increased leverage (2.9x net debt to EBITDA) and integration costs may limit near-term margin upside.

View recap

IQVIA Holdings Inc.

IQV Q2 2026

Reported: 2026-07-30

The stock surged 16.1% post-earnings, driven by clear beats across revenue, adjusted EBITDA, and EPS, with organic and segment-level growth outpacing prior expectations and margins expanding earlier than anticipated.

Key takeaways

Reported revenue grew 8.7% year-over-year, exceeding the high-end of guidance despite lower-than-expected FX tailwinds; organic growth accelerated to 6%.
Adjusted EBITDA rose 9.2% year-over-year, surpassing the top end of guidance, supported by better-than-expected operational performance and margin improvements.
Adjusted diluted EPS increased 12.1% to $3.15, also above guidance, reflecting strong underlying profitability.
Clinical R&D bookings hit $3.15 billion, up 19% year-over-year and 27% sequentially, with a book-to-bill ratio of 1.22, signaling sustained demand momentum.
Commercial segment organic growth accelerated to 5%, with analytics and consulting posting high-single-digit growth, driven by new drug launches and increased AI adoption.

View recap

Illinois Tool Works Inc.

ITW Q2 2026

Reported: 2026-07-30

Shares rose modestly by 2.7% following ITW’s Q2 report, reflecting broadly steady execution with no clear surprise to drive a stronger market response despite raised full-year guidance and margin expansion.

Key takeaways

Q2 organic growth came in at 4.5%, driven by capex-related segments: Welding (+14%), Test & Measurement and Electronics (+10%), and Polymers & Fluids (+7%).
Operating margin expanded 40 basis points to 26.7%, supported by 120 basis points from enterprise initiatives but offset partially by a temporary 40 basis points dilution from price-cost timing lag.
GAAP EPS increased 10% to $2.84, with full year EPS guidance raised to $11.45, implying 9% year-over-year growth and representing the second raise this year.
Free cash flow increased 41%, with a strong 77% conversion rate; $750 million in Q3 share repurchases were pulled into Q2.
Regional trends mixed: solid organic growth in North America and Asia Pacific (+6%), flat Europe, but Automotive OEM segment revenues largely flat with a decline in Europe (-5%).

View recap

Kering SA

KER.PA Q2 2026

Reported: 2026-07-30

Kering’s shares jumped 20.6% on the back of clear signs of operational improvements and reaccelerating brand momentum, particularly from Gucci, which showed sequential retail growth and margin improvement alongside strong engagement initiatives. The market rewarded progress toward brand desirability, inventory management, and store optimization despite ongoing macro challenges.

Key takeaways

Gucci led the turnaround with a 7-point sequential retail improvement in Q2 and all regions showing better trends.
The group completed 84 net store closures in H1 2026, continuing its store network optimization and focusing on upgrading strategic locations.
Operating margin improved alongside disciplined cost control and inventory management efforts.
Saint Laurent returned to growth, fueled by localized Asia-Pacific campaigns and strong sales in ready-to-wear and shoes.
Bottega Veneta and Balenciaga showed resilience with leather goods remaining key growth drivers; Balenciaga progressing through a creative transition with strong couture reception.

View recap

KLA Corporation

KLAC Q4 2026

Reported: 2026-07-30

Shares dropped 16.3% as investors reacted negatively to cautious commentary on the memory pricing environment and tariff headwinds, as well as subtle signs of margin pressure despite revenue and earnings beating prior guidance.

Key takeaways

Revenue reached $3.66 billion, 7% sequential growth and 15% year-over-year, above midpoint guidance.
Non-GAAP diluted EPS of $1.05 and GAAP EPS of $1.04 came in at upper guidance range.
Gross margin was 62.4%, near the high end of guidance but offset by challenges in memory pricing and tariffs.
Operating expenses totaled $682 million, including $399 million in R&D and $283 million in SG&A.
Free cash flow of $817 million supported $876 million returned to shareholders in the quarter through buybacks and dividends.

View recap

Kiniksa Pharmaceuticals, Ltd.

KNSA Q2 2026

Reported: 2026-07-30

Kiniksa shares surged 27.4% following significant upside in ARCALYST commercial performance and raised full-year revenue guidance, signaling strong execution and expanding market penetration.

Key takeaways

Q2 net revenue reached $243.6 million, up over $29 million sequentially and $85 million versus Q2 2025, marking the largest quarterly increase since launch.
Full-year 2026 revenue guidance was raised from $945 million to a range of $980 million to $995 million.
ARCALYST’s prescriber base expanded to over 5,000, with approximately 450 new prescribers added in Q2 and 29% now prescribing for multiple patients.
Penetration into the multiple recurrence patient population increased to ~21% from ~18% at the end of 2025.
The company advanced KPL-387 into Phase III trials, targeting a commercial launch in 2028–2029.

View recap

Larsen & Toubro Limited

LT.NS Q1 2027

Reported: 2026-07-30

Larsen & Toubro's shares gained 3.3% post-earnings, driven by better-than-expected order inflows and international growth, supported notably by large offshore wind awards and strong project bookings. The market rewarded the company’s expanding global footprint and resilient domestic demand despite steady domestic order growth.

Key takeaways

Group order inflows rose 14% YoY to INR 1,080 billion, led by PP&M segment orders also up 14% YoY to INR 860 billion.
International order inflows increased sharply by 27% YoY, raising their share of PP&M portfolio to 55% from 49% a year ago.
Domestic orders showed only marginal growth of 1% YoY, indicating stable but unspectacular demand at home.
Strategic initiatives continued with major offshore wind contract wins adding to an 8 GW transmission capacity secured over the past three quarters.
Moody’s upgraded L&T’s long-term issuer rating to Baa1 with a stable outlook, reflecting solid credit fundamentals despite global macro uncertainties.

View recap

Mercedes-Benz Group AG

MBG.DE Q2 2026

Reported: 2026-07-30

The 3.4% stock gain reflects investor approval of Mercedes-Benz's resilience outside China and strong industrial efficiencies, offsetting weakness from a sharp sales drop in the Chinese market and modest margin pressure.

Key takeaways

Group revenue was flat at EUR 32 billion, with the Chinese market declining about 20%, partially offset by 2% sales growth in other regions.
Adjusted EBIT increased 22% year-over-year to EUR 1.5 billion, driven by operational efficiencies and disciplined cost control.
Cars segment posted an adjusted EBIT of approximately EUR 900 million and a 4% margin, within full-year guidance, despite headwinds from weaker net pricing and supply constraints in China.
Second-generation battery electric vehicle sales rose 51%, led by Europe (+87%), supported by a strong order book heading into H2.
Free cash flow of EUR 1.1 billion and net industrial liquidity of EUR 30 billion provide financial flexibility after EUR 5 billion returned to shareholders.

View recap

Mondelez International, Inc.

MDLZ Q2 2026

Reported: 2026-07-30

Shares rose 7.1% following better-than-expected top-line growth driven by strong emerging markets performance and accelerating momentum in North America, supported by disciplined promotional execution and successful innovation.

Key takeaways

Emerging markets revenue grew 4.4% with strong volume expansion, benefiting from widened distribution (e.g., +100,000 stores added in India) and stable consumer confidence in key countries like India, Brazil, and Mexico.
North America showed sequential acceleration in net revenue growth and positive volume/mix, gaining share across all categories despite ongoing consumer affordability concerns and inflationary pressures.
The ventures portfolio, including Perfect Snacks and States You, delivered mid-to-high single-digit growth, particularly in value channels and away-from-home segments.
Innovation continues to contribute, with new product launches such as Ritz Drizzled, Sour Patch Kids chews, Oreo innovations, and Zbar fueling growth and share gains.
Management is increasing reinvestment behind promotional activities and innovation, projecting a strong second half driven by sustained channel momentum and pricing discipline.

View recap

The Bank of N.T. Butterfield & Son Limited

NTB Q2 2026

Reported: 2026-07-30

Butterfield’s Q2 results were largely in line with expectations as reflected by a modest 0.4% stock increase. While net interest income grew and non-interest income showed stability, margin compression and incremental expenses related to the R&H acquisition limited upside.

Key takeaways

Net interest income rose $2.3 million sequentially to $95.6 million, supported by higher asset volumes and an extra business day.
Net interest margin dipped slightly by 1 basis point to 2.74%, pressured by a 1 basis point increase in deposit costs.
Non-interest income was stable at $63.4 million, with trust revenues benefiting from R&H onboarding offset by weaker foreign exchange and banking fees.
Core non-interest expenses rose 3.3% sequentially to $92.9 million, driven by acquisition-related costs including higher salaries, technology, and amortization.
Share repurchases were paused following the announcement of the CIBC Caribbean acquisition, reflecting a cautious approach to capital allocation ahead of deal closure.

View recap

Nucor Corporation

NUE Q2 2026

Reported: 2026-07-30

Nucor’s 2Q results beat expectations as shipment records were set across multiple segments, supported by strong execution and ramping capital projects, driving a 3.3% stock gain. Growth in shipments and backlog strength contributed to a generally positive market reaction.

Key takeaways

Steel mill shipments reached a new record at 7.1 million tons for the second consecutive quarter.
Steel Products shipments rose 11% quarter-over-quarter, led by a record performance in the Tube group.
Return of capital to shareholders totaled $479 million, representing 41% of net earnings.
Capital expenditures were $571 million this quarter, with $2.5 billion expected for the year, primarily toward growth projects.
Strong trade enforcement efforts helped reduce finished steel imports 25% year-over-year, aiding domestic demand.

View recap

NXP Semiconductors N.V.

NXPI Q2 2026

Reported: 2026-07-30

NXP shares dropped 10% after the company’s earnings report despite management’s optimistic tone, signaling investor concerns over an overly cautious outlook and potential deceleration not reflected in the early commentary.

Key takeaways

Q2 revenue was $3.5 billion, up 19% year-over-year, with non-GAAP operating margin at 35% and EPS of $3.61, all roughly in line or slightly above guidance.
Strong growth noted across segments: automotive (+12%, up to 17% excluding MEMS sale), industrial and IoT (+38%), communication infrastructure (+41%), and mobile (+6%).
Company-specific growth drivers contributed significantly, especially in automotive (47% of segment revenue) and industrial/IoT (36% of segment revenue).
Data center exposure ramping, expected to more than double revenue contribution from ~$200 million in 2025 to over $500 million in 2026, focused on AI infrastructure control plane.
Despite the positive momentum described, the 10% stock decline likely reflects investor skepticism over the outlook’s sustainability and the lack of clarity on margin expansion or further upside, suggesting concerns about future deceleration or cautious guidance.

View recap

Grupo Aeroportuario del Centro Norte, S.A.B. de C.V.

OMAB.MX Q2 2026

Reported: 2026-07-30

OMA's shares rose modestly by 2.0% following its Q2 2026 earnings, reflecting a mixed reception to steady passenger traffic growth paired with margin expansion, but limited upside beyond expectations.

Key takeaways

Passenger traffic grew 0.4% year-over-year to 7.2 million, driven by a 0.6% increase in domestic passengers; international traffic fell 1.2%, notably at Monterrey Airport.
Aeronautical revenues rose 4%, primarily due to tariff hikes implemented in April 2026; aeronautical revenue per passenger increased 3.5%.
Non-aeronautical revenue grew 9.8%, with strong contributions from commercial services (+6.7%) and diversification activities (+17%), including a 29% rise in cargo revenues.
Adjusted EBITDA increased 6.6% to Ps. 2.7 billion, with margin expansion to 75.2%, supported by disciplined cost management despite inflationary pressures raising payroll and contracted services expenses.
The company issued Ps. 3 billion in long-term notes in July to refinance short-term debt and fund development programs, while surpassing its sustainability targets on greenhouse gas reductions.

View recap

Omnicom Group Inc.

OMC Q2 2026

Reported: 2026-07-30

Omnicom’s shares were largely unchanged following Q2 results as strong organic growth and margin expansion were offset by modest caution in outlook. The market appears to have digested the positive operational momentum without pushing the stock higher.

Key takeaways

Organic revenue growth from Core Operations was 6.1% year-over-year, driven mainly by Integrated Media and experiential services.
Adjusted EBITA expanded 20.4%, with margins increasing approximately 200 basis points to 17.8%.
Non-GAAP adjusted EPS rose 29.3% to $2.65 per share, excluding various non-recurring costs.
The company maintained disciplined capital allocation, completing $3 billion of a $5 billion share repurchase plan.
Full-year 2026 organic revenue growth guidance was raised modestly to a 4.5%–5% range, reflecting confidence tempered by prudent outlook given recent macro uncertainties.

View recap

OPKO Health, Inc.

OPK Q2 2026

Reported: 2026-07-30

OPKO Health's shares surged 35.2% following Q2 2026 results, driven primarily by clear progress across multiple clinical pipeline programs and sustained financial strength, which appear to have exceeded investor expectations.

Key takeaways

ModeX advanced five clinical trial programs spanning oncology, immunology, and vaccines, with an anticipated sixth in vivo CAR-T asset to enter clinical trials by end of 2026 or early 2027.
Merck-funded MDX2201 vaccine against Epstein-Barr virus is completing Phase I data analysis, with Phase II study design expected by year-end.
Early clinical milestones for MDX2001, MDX2003, MDX2004, and MDX2301 highlight diversified pipeline activity, including ongoing Phase I trials and planned data presentations in late 2026 and 2027.
Solid balance sheet and operating efficiency improvements sustained a strong cash position while enabling continued R&D funding and capital return via stock repurchases.
Collaborations with Regeneron and BARDA bolster pipeline breadth, supporting late-stage immuno-oncology and infectious disease programs underpinned by multi-specific antibody platform technology.

View recap

Orange S.A.

ORA.PA Q2 2026

Reported: 2026-07-30

The stock gained 6.0% following an earnings release highlighted by an upgraded 2026 EBITDAaL guidance and improved cash flow outlook, driven by strong performance in France and Europe, as well as the accretive contribution from the MasOrange transaction.

Key takeaways

Raised 2026 EBITDAaL guidance to above 4%, reflecting solid operations in France and improved prospects across Europe and Africa, Middle East.
Organic cash flow guidance increased to approximately EUR 4.3 billion, supported by MasOrange’s cash contribution.
The MasOrange transaction is expected to provide immediate EBITDAaL accretion of EUR 900 million with low incremental CapEx and manageable integration costs.
Announced a new data center project to unlock asset value and create a co-controlled entity with no equity contribution from Orange; expected to generate dividends, revenue, margin, and cost efficiencies over time.
French regulatory review of the transaction is on track with expectations, targeting closing in H2 next year despite an 18-month review timeline.

View recap

Orange S.A.

ORANY Q2 2026

Reported: 2026-07-30

The stock rose 6.2% following the earnings release, reflecting investor approval of the raised 2026 EBITDAaL and organic cash flow guidance, supported by solid performance in France and improved outlook in Europe and Africa, Middle East.

Key takeaways

Company raised 2026 EBITDAaL margin guidance to above 4%, incorporating MasOrange for 7 months.
Organic cash flow guidance upgraded to circa EUR 4.3 billion, driven by accretive cash contribution from MasOrange.
Solid business performance in France coupled with improved outlook for Europe and Africa, Middle East supported revised guidance.
French regulatory review of the French consolidation transaction expected to conclude H2 next year; process aligned with prior expectations despite media speculation on timeline.
Data center project announced aims to unlock value from existing assets, create a co-controlled entity with no equity contribution from Orange, and deliver dividends plus operational efficiencies over time.

View recap

PJT Partners Inc.

PJT Q2 2026

Reported: 2026-07-30

Shares declined 2.2% following earnings despite record revenue and profit marks, likely reflecting investor concerns over rising non-compensation expenses and cautious guidance on expense growth.

Key takeaways

Second quarter revenues hit $486 million, a 20% year-over-year increase, with all business segments contributing growth.
Adjusted pretax income rose 32% to $106 million, with margin expansion to 21.7% from 19.7% a year ago.
Adjusted EPS reached $1.97, up 28%, both second quarter and first half records.
Non-compensation expenses increased 10% year-over-year in Q2 and are now expected to grow about 14% for the full year, higher than prior guidance, driven by elevated travel, professional fees, and technology investments.
Strong cash position of $535 million with no funded debt; the company repurchased 498,000 shares in the quarter and declared a $0.25 quarterly dividend.

View recap

Pentair plc

PNR Q2 2026

Reported: 2026-07-30

Shares rose 5.4% following Pentair’s earnings as Water Solutions and Flow segments delivered strong returns and the company reaffirmed full-year adjusted EPS guidance, offsetting concerns around pool segment softness and inventory adjustments.

Key takeaways

Pool segment sales declined year-over-year due primarily to an unexpectedly large inventory realignment by major pool channel partners and ongoing end-market pressures in North America.
Water Solutions and Flow businesses achieved record return on sales, demonstrating continued underlying strength outside the pool segment.
Adjusted operating income benefited from approximately $35 million of tariff refunds across all segments in the quarter.
The company repurchased $150 million of shares during the quarter, signaling confidence in long-term value creation.
Management initiated a comprehensive review and outlined a clear action plan to address near-term pool challenges, focusing on dealer engagement, marketing realignment, and innovation to restore growth by 2027.

View recap

PayPal Holdings, Inc.

PYPL Q2 2026

Reported: 2026-07-30

Shares rose 4.1% following an earnings report that showed better-than-expected execution, driven by revenue growth and margin improvement alongside raised full-year guidance.

Key takeaways

Revenue increased 5% year-over-year, supported by strong growth in Venmo, Credit, and Braintree.
Transaction margin dollars (TM) grew 1%, or 3% excluding interest on customer balances, indicating modest margin improvement.
Branded checkout total payment volume stabilized, increasing 2% on a currency-neutral basis, consistent with the prior quarter.
Venmo and Braintree delivered mid-teens percentage growth in total payment volume, continuing positive momentum in key segments.
Full-year guidance was raised for transaction margin dollars, non-GAAP EPS, and online branded checkout growth to the low single-digit range.

View recap

Ribbon Communications Inc.

RBBN Q2 2026

Reported: 2026-07-30

Ribbon’s shares rose 7.4% following Q2 results that showed stronger-than-expected bookings and sequential revenue growth, particularly driven by record demand in the IP Optical segment and expanding U.S. enterprise opportunities.

Key takeaways

Revenue grew 18% sequentially to $192 million, with product and service revenue up 28% sequentially excluding maintenance.
IP Optical segment bookings reached an all-time high with a book-to-bill ratio of 1.6x, driving a backlog increase of over 60% year-to-date.
Strong U.S. market growth contributed to improved margins, with IP Optical Apollo solution revenue up over 70% sequentially.
Cloud & Edge segment showed year-over-year declines due to lower Verizon sales but improved margins sequentially driven by a higher mix of product revenue.
Ribbon secured a significant partnership with Salesforce to support AI-powered contact center deployments, highlighting new market opportunities.

View recap

Rio Tinto Group

RIO.L Q2 2026

Reported: 2026-07-30

The stock rose modestly by 2.1% following the earnings release as the company showed operational improvements and productivity gains, but the market remained cautious, reflecting tempered enthusiasm about near-term upside.

Key takeaways

Copper equivalent production increased by 3%, demonstrating steady volume growth.
Free cash flow surged by 75%, supporting a 43% higher interim dividend of $3.4 billion.
Productivity programs exceeded initial targets, delivering $870 million in benefits to date, with a year-end run rate target of $1.8 billion.
Growth is driven by strong execution on major projects including 75% completion at Simandou and ramp-up at OT.
Market reaction suggests the results neither disappointed nor significantly exceeded expectations, indicating investors are watching for sustained momentum.

View recap

Rithm Capital Corp. Common Stock

RITM Q2 2026

Reported: 2026-07-30

The stock gained 8.2% following better-than-expected execution across Rithm Capital’s diversified platform, particularly driven by strong asset management performance and robust mortgage origination volumes.

Key takeaways

GAAP net income totaled $338.9 million or $0.60 per diluted share, supported by effective hedging activities around the substantial $850 billion MSR portfolio.
Book value remained essentially flat at approximately $12.50 per share, reflecting stable capital amidst dividend payouts and asset depreciation.
The asset management business has scaled rapidly from zero third-party AUM in 2023 to over $61 billion currently, demonstrating strong client traction and diversification.
Newrez originations are projected at about $65 billion for 2026 with a customer base exceeding 4 million homeowners.
Genesis’ residential transitional lending has expanded materially since 2022, now approaching $7 billion in annual production, highlighting operational growth despite volatile markets.

View recap

Safran SA

SAF.PA Q2 2026

Reported: 2026-07-30

Safran’s shares rose modestly by 2.0% post-earnings, reflecting a broadly in-line result with a strong civil engine aftermarket and robust volume ramps but with no major upside surprise to push the stock higher.

Key takeaways

Revenue grew 20% organically to EUR 17.6 billion, driven by increased civil engine deliveries and aftermarket services.
Recurring operating income rose 29% to EUR 3.2 billion, translating into a record 18.4% operating margin.
Free cash flow improved 43% to EUR 2.6 billion, supported by operational leverage and working capital management.
LEAP engine deliveries surged 41% year-over-year with continued ramp-up and expanding third-party maintenance activity.
Management raised full-year guidance reflecting strong visibility but geopolitical risks remain a backdrop.

View recap

The Sherwin-Williams Company

SHW Q2 2026

Reported: 2026-07-30

Sherwin-Williams shares rose 5.1% following better-than-expected sales and margin performance, supported by broad-based growth and an increased full-year guidance. Investors rewarded execution on new account wins, pricing discipline, and margin expansion despite ongoing demand challenges.

Key takeaways

Consolidated sales grew by a high single-digit percentage, including a low single-digit contribution from the Suvinil acquisition.
Adjusted EBITDA increased 10.5% to $1.5 billion with margin expansion of 60 basis points to 21.5%.
Paint Stores Group delivered mid single-digit sales growth, with volume and price/mix gains and segment margin at 24.6%.
Consumer Brands Group sales were lifted by Suvinil and showed mid single-digit price/mix gains despite volume declines in some regions; adjusted segment margin improved by 210 basis points.
Management raised full-year sales and EPS guidance, reflecting confidence in ongoing execution and incremental pricing actions planned for September.

View recap

Tilray, Inc.

TLRY Q4 2026

Reported: 2026-07-30

Tilray’s shares declined 1.0% following its fiscal 2026 earnings as the broad results and commentary failed to clearly offset investor concerns around growth momentum and margin outlook in key segments.

Key takeaways

Fiscal 2026 marks Tilray’s evolution into a diversified global operator across cannabis, beverages, hospitality, and wellness, with leadership in multiple markets.
The company highlighted scale with over $700 million in operating assets, $235 million cash and marketable securities, and net debt near breakeven.
Tilray claims industry-leading positions including largest cannabis cultivator globally (6 million sq. ft.), medical cannabis leadership in Europe, and a top 100 global beverage presence boosted by the BrewDog acquisition.
Despite diversified revenues and cash flow generation, the market reaction suggests investor skepticism remains around growth visibility, margin sustainability, or the impact of recent acquisitions.
Commentary emphasized long-term value creation rather than near-term financial outperformance, indicating cautious investor sentiment on current earnings and outlook.

View recap

TransUnion

TRU Q2 2026

Reported: 2026-07-30

The market reacted positively, up 8.4%, reflecting TransUnion’s earnings and raised full-year guidance that beat expectations on organic revenue growth and adjusted diluted EPS, driven by broad-based strength across segments and continued innovation momentum.

Key takeaways

Organic constant currency revenue grew 10% in Q2, above prior guidance of 8-9%, with U.S. markets up 11%, led by Financial Services at +18%.
Adjusted diluted EPS increased 13% year-over-year, underpinning raised full-year guidance to 11-12% growth, up from 9-11%.
The firm highlighted progress on its OneTru platform migration with 60% of U.S. match activity now on the new system, enhancing innovation velocity with 40 new AI-powered product launches in H1.
Emerging verticals grew 9%, with strong double-digit growth in insurance and robust results internationally, including high single-digit growth in India and the U.K.
The company reduced leverage to 2.6x and repurchased approximately $150 million of stock year-to-date, maintaining capacity for further buybacks under its $1 billion authorization.

View recap

Tamarack Valley Energy Ltd.

TVE.TO Q2 2026

Reported: 2026-07-30

Tamarack Valley Energy’s Q2 results were bolstered by strong Clearwater production growth and elevated commodity prices, driving a 3.1% stock gain that reflects investor approval of the company’s robust cash flow generation and disciplined capital allocation.

Key takeaways

Adjusted funds flow reached a record $255 million ($0.53/share), up 29% year-over-year, underpinning strong cash generation.
Free funds flow for Q2 totaled $155 million after capital spending, with year-to-date free funds flow at $280 million ($0.58/share).
Production from the Clearwater formation exceeded 54,000 BOE per day, with waterflood-enhanced barrels accounting for 16% of Q2 Clearwater output.
Capital spending increased by $75 million beyond original 2026 budget to accelerate growth in high-margin Clearwater assets, targeting up to $450 million total for the year.
Balance sheet strength improved significantly following the Charlie Lake divestiture, with net cash of $130 million and over $500 million liquidity on hand, enabling share buybacks that have reduced the share count by 15% since January 2024.

View recap

Textron Inc.

TXT Q2 2026

Reported: 2026-07-30

Textron shares declined 10.9% following the quarter as investors reacted negatively to ongoing production challenges and cautious commentary on operational execution, despite solid demand and backlog growth. The market appears focused on the company’s internal execution risks and supply chain issues rather than top-line increases.

Key takeaways

Revenue grew 3% in Q2 and 7% year-to-date, driven by ongoing strength across manufacturing segments, with Textron Aviation up 1% and Bell up 6%.
Aviation backlog remains robust at $8 billion with strong demand for jets and turboprops; deliveries included 40 jets and 44 turboprops, though jet deliveries declined year-over-year.
Production challenges persist, including supply chain pain points and a need to improve workforce efficiency despite normalized attrition and ramped hiring.
Investments are underway to improve factory execution and engineering producibility, along with efforts to expand capacity in key areas like landing gear and paint.
Bell’s MV-75 Cheyenne program progresses with significant labor hour reductions on wing builds, but funding uncertainty adds risk, with Textron prepared to self-fund in the near term.

View recap

Unilever PLC

ULVR.L Q2 2026

Reported: 2026-07-30

Unilever’s strong volume-led growth and margin expansion drove a positive market reaction (+7.8%), reflecting investor approval of better-than-expected broad-based execution and brand momentum supported by strategic marketing investments.

Key takeaways

Underlying sales grew 5.8% in Q2, with volume up 5.5%, marking the best quarterly volume performance since 2010.
Power brands delivered 6.9% underlying sales growth, driven by innovation and concentrated marketing spend.
HPC segment grew 7.6% in underlying sales with volume up 7.4%, showing strong operational execution in key categories.
Emerging markets maintained momentum, with 8.3% underlying sales growth; India outperformed with 10% sales growth and 5% volume increase.
Margins expanded by 10 basis points despite ongoing investments, supporting 2.4% earnings growth in hard currency.

View recap

United Parcel Service, Inc.

UPS Q2 2026

Reported: 2026-07-30

UPS shares dropped 7.4% following Q2 results as investors were disappointed by cautious outlook comments and margin pressures despite revenue growth, signaling concerns over near-term profitability and the impact of transformation costs.

Key takeaways

Consolidated revenue grew 7.6% year-over-year to $22.8 billion, reflecting broad-based strength across all segments.
Operating profit increased 12% to $2.1 billion; however, operating margin expansion was modest at 9.2%, up only 40 basis points year-over-year.
Transformation charges related to the Driver Choice program totaled $891 million after tax, weighing on GAAP earnings.
Management highlighted the completion of a major network reconfiguration reducing lower-quality Amazon volume by 2 million pieces daily and cutting $4.5 billion in related expenses.
While technology investments in RFID and AI promise long-term efficiency gains, near-term uncertainties and margin compression overshadowed these initiatives, contributing to investor caution.

View recap

Visa Inc.

V Q3 2026

Reported: 2026-07-30

Visa’s shares rose modestly by 1.7% following Q3 fiscal 26 results that showed steady revenue and volume growth but lacked a clear catalyst to drive a stronger market response. Despite solid execution across payments and product innovation, the stock’s muted move suggests investors took a cautious view on the outlook or margin progression.

Key takeaways

Net revenue increased 14% year-over-year to $11.6 billion, with EPS up 11%, both reported as ahead of expectations.
Quarterly payment volumes grew 10% in constant dollars to surpass $4 trillion for the first time, a notable milestone.
Processed transactions rose 10% year-over-year to 72 billion, signaling resilient consumer spending.
Commercial and money movement revenues expanded 17% year-over-year, supported by 13% growth in commercial payment volumes.
Visa accelerated product innovation, including AI deployment across enterprise functions and enhancements in Visa Direct, yet investors appear cautious given the sub-3% share move.

View recap

Earnings Recaps

L'Air Liquide S.A.

American Tower Corporation (REIT)

Applied Science Products, Inc.

The Boeing Company

Basic-Fit N.V.

Banco Latinoamericano de Comercio Exterior, S.A

Brixmor Property Group Inc.

Cincinnati Financial Corporation

Celestica Inc.

CenterPoint Energy, Inc.

Croda International Plc

CoStar Group, Inc.

CTS Corporation

Ecolab Inc.

EssilorLuxottica Societe anonyme

Man Group plc

Ford Motor Company

Corning Incorporated

Grifols, S.A.

GlaxoSmithKline plc

Hilton Worldwide Holdings Inc.

Hubbell Incorporated

IQVIA Holdings Inc.

Illinois Tool Works Inc.

Kering SA

KLA Corporation

Kiniksa Pharmaceuticals, Ltd.

Larsen & Toubro Limited

Mercedes-Benz Group AG

Mondelez International, Inc.

The Bank of N.T. Butterfield & Son Limited

Nucor Corporation

NXP Semiconductors N.V.

Grupo Aeroportuario del Centro Norte, S.A.B. de C.V.

Omnicom Group Inc.

OPKO Health, Inc.

Orange S.A.

Orange S.A.

PJT Partners Inc.

Pentair plc

PayPal Holdings, Inc.

Ribbon Communications Inc.

Rio Tinto Group

Rithm Capital Corp. Common Stock

Safran SA

The Sherwin-Williams Company

Tilray, Inc.

TransUnion

Tamarack Valley Energy Ltd.

Textron Inc.

Unilever PLC

United Parcel Service, Inc.

Visa Inc.

Community

Trending This Week

Notifications